If the Nats can make the NLCS without Bryce Harper, surely Washington can pass drug pricing reform by the end of the year.
The drug lobby is throwing mounds of cash around in an attempt to convince lawmakers that drug pricing’s status quo should remain. Voters disagree!
TL;DR of PhRMA's statement on the House plan to lower drug prices? "We're good with the high prices, thanks."
A leaked draft of a House plan to empower the U.S. government to negotiate drug prices injects enthusiasm into the drug pricing debate and overlaps with President Trump’s plan.
Taxpayer negotiation is a linchpin that will lower drug prices; it’s time for bipartisan action on voters’ top priority.
Pharma is siphoning hourly wages from the pockets of hard-working Americans.
Fact Check on Big Pharma’s Attacks on the Administration’s Proposed Part B Reforms.
A judge said HHS can’t make Big Pharma put its list prices in TV ads. HHS is pushing back.
We want patients to buy prescriptions at reasonable prices, but we can’t rely on our northern neighbor forever.
Campaign Relaunches in Light of Recent Setbacks For Administration Blueprint
"More than 3,400 drugs have boosted their prices in the first six months of 2019, an increase of 17% in the number of drug hikes from a year earlier."
Colorado is the first state to place a price cap on out-of-control insulin prices.
New data from the Centers For Medicare & Medicaid Services emphasized the need for Congress to pass the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions.
Maryland lawmakers can take a stand today on one of the most important issues facing residents — rising prescription drug prices.